Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Carcinoma: early-phase trial registry
21 of 39 indexed Lung Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #382 of 28,707 conditions by registered trial count.
39 US clinical trials · 21 currently recruiting · #382 of 28,707 conditions by registered trial count
Lung Carcinoma: 39 US clinical trials tracked, 21 recruiting.
Lung Carcinoma is the subject of 39 registered US clinical trials on ClinicalTrials.gov, 21 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 9 of these trials.
Enrollment posture brief
Registry condition lung-carcinoma
OPEN 21 | RECR 54% | LATE 0 | EARLY 9 | RANK #382 | SPON 9
Volume-matched condition peers
Nearest open-share peer: Advanced Renal Cell Carcinoma (54% recruiting · 13 trials)
Lung Carcinoma lists 21 open slots (54% of 39 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Carcinoma is recruiting above its size-band peers.
21 of 39 indexed trials (53.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Lung Carcinoma research.
M.D. Anderson Cancer Center accounts for 9 of 39 trials (23.1%). 19 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Carcinoma enrolment sits around 100 participants.
Median target enrolment is 100 among the 39 trials that report a genuine target (sentinel values excluded). 19 of those (48.7%) plan for fewer than 100 participants.
-
Lung Carcinoma research is mostly interventional.
35 interventional and 4 observational studies make up this index (89.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
39 total, page 1 of 1
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
NCT06995898
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
M.D. Anderson Cancer Center
NCT00991094
Lung Cancer Screening in High-risk Black Individuals
Massachusetts General Hospital
NCT05898594
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Ronald Myers
NCT05679349
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
M.D. Anderson Cancer Center
NCT04595422
Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
Jonsson Comprehensive Cancer Center
NCT05978128
The Rise in Robotic Atypical Segmentectomies
M.D. Anderson Cancer Center
NCT04644952
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
City of Hope Medical Center
NCT06196008
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
OHSU Knight Cancer Institute
NCT05407168
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
M.D. Anderson Cancer Center
NCT04783168
Engagement of Veterans With Lung Cancer
Palo Alto Veterans Institute for Research
NCT07219251
CONNECTing to LungCare
University of California, San Francisco
NCT06213532
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
City of Hope Medical Center
NCT05384769
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
M.D. Anderson Cancer Center
NCT06743308
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
University of Michigan Rogel Cancer Center
NCT07291414
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
Northwestern University
NCT05802186
Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
M.D. Anderson Cancer Center
NCT04789681
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
Mayo Clinic
NCT06482073
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Stanford University
NCT03582124
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
M.D. Anderson Cancer Center
NCT03422302
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Thomas Jefferson University
NCT05775939
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
NCT01696968
Yoga Program for Improving the Quality of Life in Couples Coping With Cancer
M.D. Anderson Cancer Center
NCT04607590
HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics
City of Hope Medical Center
NCT04905082
Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study
Fred Hutchinson Cancer Center
NCT04081779
Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer
M.D. Anderson Cancer Center
NCT05144542
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
NCT01366144
Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial
Ohio State University Comprehensive Cancer Center
NCT06445192
Metformin for Chemoprevention of Lung Cancer in Overweight or Obese Individuals at High Risk for Lung Cancer
Northwestern University
NCT04931017
Endobronchial Ultrasound-Guided Transbronchial Needle-Aspiration With Suction in Obtaining Samples From Patients With Suspected Nodal Metastatic Lung Cancer
Ohio State University Comprehensive Cancer Center
NCT04116970
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer
National Cancer Institute (NCI)
NCT03300817
Evaluation of Canakinumab in High-Risk Former-Smokers
Peter Shields
NCT06038526
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
Jonsson Comprehensive Cancer Center
NCT04147494
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Julie L. Sutcliffe, Ph.D
NCT03164486
Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV
Fred Hutchinson Cancer Center
NCT04682301
Iloprost in Preventing Lung Cancer in Former Smokers
National Cancer Institute (NCI)
NCT02237183
Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study
Fred Hutchinson Cancer Center
NCT04922697
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
University of Washington
NCT01982123
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy
OHSU Knight Cancer Institute
NCT03135782
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Lung Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Carcinoma page
39 registered trials, 21 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 21 Lung Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Lung Carcinoma trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Carcinoma condition card totals 39 registered trials; most-linked intervention Questionnaire Administration; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.